Sotiria General Hospital
8
3
3
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
50%
1 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Tirzepatide vs Liraglutide in Bone
Role: collaborator
DUET Versus Standard Interface for Hypercapnic COPD Patients
Role: collaborator
Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)
Role: collaborator
Assessment of Nutritional Status of Patients With Crohn's Disease
Role: collaborator
Dexmedetomidine and Morphine as Adjuvants to US Guided Erector Spinae Plane Blocks in Elective Thoracic Surgeries
Role: collaborator
Bi-PAP vs Sham Bi-PAP on Pulmonary Function in Morbidly Obese Patients After Bariatric Surgery
Role: collaborator
NHF vs NIV in Patients With Acute Exacerbation of COPD
Role: collaborator
A Study on the Effect of Mepolizumab Therapy on Daily Physical Activity of Patients With Severe Eosinophilic Asthma
Role: lead
All 8 trials loaded